Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Bausch Health Companies Inc.

Get SEC filing alerts via email and in your feed for Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

About Bausch Health Companies Inc.

Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company focused on gastroenterology, hepatology, neurology, dermatology, and eye health through its majority-owned Bausch + Lomb subsidiary. It develops, manufactures, and markets branded, generic, and OTC pharmaceuticals, aesthetic medical devices, and eye care products across approximately 90 countries. The company leverages a diversified portfolio, extensive R&D, and a broad commercial footprint targeting healthcare providers, patients, and consumers worldwide.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Bausch Health Companies Inc.

1
1
Bausch Health Companies Inc. Bausch Health Reports 12% Revenue Growth to $2.524 Billion in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Bausch Health Companies Inc. Bausch Health Companies Inc. Reports $10.27 Billion Revenue for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Bausch Health Companies Inc. Bausch Health Reports 7% Revenue Growth to $2.681 Billion in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Bausch Health Companies Inc. Bausch Health Reports 5% Revenue Growth to $2.53 Billion in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Bausch Health Companies Inc. Bausch Health Reports 5% Revenue Increase to $2.259 Billion in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Bausch Health Companies Inc. Bausch Health Companies Reports $9.625 Billion Revenue for 2024, Net Loss Improves to $72 Million

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Bausch Health Companies Inc. Bausch Health Reports 12% Revenue Growth, Improved Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments